ScholarIQanswers from OpenAlex
Prince of Wales Hospital
InstitutionResearch output, impact & collaborations
Prince of Wales Hospital is a institution indexed in ScholarIQ from OpenAlex.
What is known about Prince of Wales Hospital?
ScholarIQrecord summary
Prince of Wales Hospital is a research organisation in Shatin, CN. OpenAlex records 21,789 works and 2,802,896 citations for it. 5,699 researchers list it as their most recent affiliation.
How many works does Prince of Wales Hospital have?
ScholarIQindexed works
Prince of Wales Hospital has 21,789 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Prince of Wales Hospital have?
ScholarIQcitation count
Prince of Wales Hospital has 2,802,896 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Prince of Wales Hospital?
ScholarIQresearcher count
Prince of Wales Hospital has 5,699 researchers in the ScholarIQ index.
What is the average h-index at Prince of Wales Hospital?
ScholarIQavg h-index
Prince of Wales Hospital has an average h-index of 105 in OpenAlex.
What is the ROR of Prince of Wales Hospital?
ScholarIQror
The ROR for Prince of Wales Hospital is on the source record.
What is the OpenAlex record for Prince of Wales Hospital?
ScholarIQopenalex
The OpenAlex for Prince of Wales Hospital is on the source record.
Who are the most-cited researchers behind Prince of Wales Hospital?
ScholarIQtop researchers by citations
What are the most-cited papers on Prince of Wales Hospital?
ScholarIQmost cited works
Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis
Pierre Blanchard, Anne Lee, Sophie Marguet, Julie Leclercq, Wai Tong Ng, Jun Ma, Anthony T.�C. Chan, Pei‐Yu Huang, E Benhamou, Guopei Zhu, Daniel T. T. Chua, Yong Chen, Hai‐Qiang Mai, Dora L.�W. Kwong, Shie Lee Cheah, James Moon, Yuk Tung, Kwan‐Hwa Chi, George Fountzilas, Li Zhang, Edwin P. Hui, Tai‐Xiang Lu, Jean Bourhis, Jean‐Pierre Pignon
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette Ma, Wan‐Teck Lim, Boon Cher Goh, Edwin P. Hui, Kwok Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean Lim, Ka‐Fai To, K.C. Allen Chan, Yuk Ming Dennis Lo, Ann D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.�C. Chan
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
Laureen Ribassin-Majed, Sophie Marguet, Anne W.M. Lee, Wai Tong Ng, Jun Ma, Anthony T.�C. Chan, Pei‐Yu Huang, Guopei Zhu, Daniel T. T. Chua, Yong Chen, Hai-Qiang Mai, Dora L.�W. Kwong, Shie-Lee Cheah, James Moon, Yuk Tung, Kwan-Hwa Chi, George Fountzilas, Jean Bourhis, Jean‐Pierre Pignon, Pierre Blanchard, on behalf of the Meta-Analysis of Chemotherapy in Nasopharyngeal Collaborative Group
Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Anthony T.�C. Chan, Mow-Ming Hsu, Boon Cher Goh, Edwin P. Hui, Tsang‐Wu Liu, Michael Millward, Ruey‐Long Hong, Jacqueline Whang‐Peng, Brigette Ma, Ka‐Fai To, M. Mueser, Nadia Amellal, Xiao Lin, Alex Y. Chang
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
Jianming Ying, H Li, T J Seng, Cordelia Langford, Gopesh Srivastava, Sai Wah Tsao, Thomas Choudary Putti, Paul G. Murray, Anthony T.�C. Chan, Qian Tao
How much of the research on Prince of Wales Hospital is open access?
ScholarIQopen access share
33%OPEN ACCESS